Posted by: Chris Maloney | October 11, 2014

Dr. Oz Talks About Spreading Ebola In the U.S.

When Sierra Leone has given up on Ebola and is turning patients away to die at home, it’s time to seriously reconsider our priorities as a nation.

If Sierra Leone had a massive Tsunami, or if they had an earthquake or a flood, we’d be pouring resources into the country to help them recover. But because Ebola is contagious, we’re not sending in rescue workers. And because we aren’t committing to containing Ebola now, we’re setting ourselves up for outbreaks in other countries.

Ebola is easier to get than we’ve been told. It isn’t airborne (see previous post) but it is passed by any contact to the eyes or mouth from dried blood. That means if you are caring for a person with Ebola, and touch your eyes, you can become infected.

We cannot expect that those with the resources to leave West Africa will stay there. They will leave and go somewhere safe, even as far as Oklahoma city. Here’s Dr. Oz talking about the risks:

and the raw interview here:

“Imagine if the virus smolders for generations.”

He’s right, we need to do more to make sure that the virus dies out in West Africa. We can’t continue to play catch up and defense.

I’ve written previously about preliminary studies of Ebola and the possibility of green tea helping discourage viral growth. There’s a lotion out now that may do the same thing:

In my same post, I talked about the fact that adding vitamin C in a patient’s arm didn’t save them. But what about avoiding vitamin C deficiency to begin with? There are no studies on vitamin C status and Ebola patients. But a study on the disease progression in monkeys shows that the virus breaks down the coagulation cascade. In other words, patients with Ebola don’t bleed because of connective tissue breakdown, they bleed because the Ebola virus acts like uncontrolled coumadin in the system.

Which leads to the thought, what if the patients were injected with Vitamin K, not Vitamin C? We have Vitamin K available. It’s used nationwide for newborns. There’s no shortage.

Maybe it would work, maybe it wouldn’t. But right now, we’re waiting for pharmaceutical companies to upregulate production on experimental drugs while the possibility of cheap, supportive measures are being ignored.



  1. […] survived. I wonder at this treatment, as the Ebola virus itself seems to act as an anti-coagulant. (here) I would argue that Vitamin K (which aids coagulation) would have a better outcome, but we have no […]

Tell me what you think!

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: